Quick links
Related article in
-
Case ReportSeptember 1, 2007
0
71
14
Treatment of Acute Arterial Thrombosis after Total Hip Replacement Arthroplasty Using Urokinase -A Report of Two Cases-
Yong-Sik Kim, M.D., Seung-Koo Rhee, M.D., Jin-Wha Chung, M.D., Byung-Yoon Sung, M.D., Soon-Yong Kwon, M.D.
J Korean Hip Soc 2007; 19(3): 197-203Arterial thrombosis of the lower extremity following total hip replacement is a rare but serious complication that threatens the lower limb and sometimes the life of the patient.
We report two cases of an arterial occlusion after total hip arthroplasty. The cause of the occlusion is believed to be a thromboembolism in elderly patients due to underlying artherosclerosis. In the case of multifocal artherosclerosis, a vein graft is not feasible and an infusion of a thrombolytic drug is the optimal treatment. However, the result of this method varies.
Cite
Share
PDF- 1
Vol.36 No.1
Mar 01, 2024, pp. 1~75
Most Keyword
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most View
-
Pathophysiology and Treatment of Gout Arthritis; including Gout Arthritis of Hip Joint: A Literature Review
Yonghan Cha, MD
Hip Pelvis 2024; 36(1): 1-11
, Jongwon Lee, MD , Wonsik Choy, MD , Jae Sun Lee, PhD*,† , Hyun Hee Lee, MD‡ , Dong-Sik Chae, MD‡ -
Treatment of Osteoporosis after Hip Fracture: Survey of the Korean Hip Society
Jung-Wee Park, MD
Hip Pelvis 2024; 36(1): 62-69, Je-Hyun Yoo, MD* , Young-Kyun Lee, MD , Jong-Seok Park, MD† , Ye-Yeon Won, MD‡
Editorial Office
Laboratory tests performed in hip fracture patients. CTX: carboxy-terminal telopeptide of collagen I, PTH: parathyroid hormone, P1NP: procollagen type I N propeptide, U/A: urinalysis.|@|~(^,^)~|@|First-line treatment option for osteoporosis in hip fracture patients. BP: bisphosphonate, PTH: parathyroid hormone, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|Osteoporosis medication in patients with rebound phenomenon after cessation of denosumab. Ca+Vit. D: calcium and vitamin D, PTH: parathyroid hormone, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|The most important recognized factor for atypical femoral fracture.|@|~(^,^)~|@|Preferred osteoporosis medications after cessation of bisphosphonate in patients with atypical femoral fracture. PTH: parathyroid hormone, Ca+Vit. D: calcium and vitamin D, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|Preferred osteoporosis medications in patients with high-risk of atypical femoral fracture. Ca+Vit. D: calcium and vitamin D, SERM: selective estrogen receptor modulator, PTH: parathyroid hormone.
Hip Pelvis 2024;36:62~69 https://doi.org/10.5371/hp.2024.36.1.62
© H&P
© 2024. The Korean Hip Society. Powered by INFOrang Co., Ltd